SBAs and antigen can just be ad-mixed without prior complexation or formulation4, 5, or simply be injected in an ablated tumour to boost antigen-specific CD8+ T-cell responses (Fig. 1a,b)11. This evidence concerns the gene CD8A and neoplasm.